Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Fluoroscopic system can improve targeting of lung lesions

Publish date:: November 4, 2019

Key clinical point: An electromagnetic navigation bronchoscopy system that incorporates fluoroscopic navigation can improve targeting of peripheral lung lesions.

Major finding: The system, Medtronic’s superDimension navigation system (version 7.2), increased the percentage of cases in which the target overlapped with the lesion, from 60% to 83%.

Study details: Prospective study of 50 patients.

Disclosures: This study was sponsored by Medtronic. Dr. Bhadra disclosed relationships with Medtronic, Boston Scientific, BodyVision, Auris Surgical Robotics, Intuitive Surgical, Veracyte, Biodesix, Merit Medical Endotek, and Johnson & Johnson.

Citation:

Bhadra K et al. CHEST 2019. doi: 10.1016/j.chest.2019.08.314.

This Week's Must Reads

Some MCL patients can safely stop venetoclax-ibrutinib, study suggests,

BCL11A-directed gene therapy advances in sickle cell disease,

KTE-X19 produces highest response rate in MCL subgroup,

Residual cancer burden linked to long-term survival,

House passes drug pricing bill, likely ending its journey,

Must Reads in Lung Cancer

Benefits and Drawbacks Found for Risk-Based Lung Cancer Screening Tools,

Patient-Reported Outcomes Support First-Line Pembrolizumab for NSCLC,

Single-Fraction Radiation Misses Mark for Spinal Compression Relief,

Neoantigen Vaccine Appears Safe and Active in NSCLC,

Lorlatinib Induces Deep Responses in ROS1-Positive NSCLC,